← FDA Medical Device Classifications

Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

QOF · Class II — Moderate Risk (510(k) clearance required) · Microbiology · 21 CFR 866.3981

Classification

FDA Product Code
QOF
Device class
Class II — Moderate Risk (510(k) clearance required)
Regulation
21 CFR 866.3981
Review panel
MI
Medical specialty
Microbiology
Submission type
1
GMP exempt
N
Life sustaining
N
Implant
N
Third-party review
N

Definition

A device to detect and identify nucleic acid targets in respiratory specimens from microbial agents that cause the SARS-CoV-2 respiratory infection and other microbial agents when in a multi-target test is an in vitro diagnostic device intended for the detection and identification of SARS-CoV-2 and other microbial agents when in a multi-target test in human clinical respiratory specimens from patients suspected of respiratory infection who are at risk for exposure or who may have been exposed to these agents. The device is intended to aid in the diagnosis of respiratory infection in conjunction with other clinical, epidemiologic, and laboratory data or other risk factors.

Market data

Cleared 510(k) submissions
32
Registered establishments
30

Source

Authoritative
FDA Device Classification database
Machine
JSON-LD · Markdown